Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts)) María Luisa Gutiérrez García; Raquel Gómez Perosanz; Juan Manuel Acedo Sanz; Alberto Delgado-Iribarren García-Campero; Itziar Claudio Domínguez; Angela Domenech Gómez-Imaz; Montserrat Pérez Encinas; Inés de la Fuente Hermosín; Aurora Fabero Jimenez; Conrado M. Fernández Rodríguez;

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy Joan Martínez-Campreciós; Mar Riveiro-Barciela; Raquel Muñoz-Gómez; María-Carlota Londoño; Mercé Roget; Miguel Ángel Serra; Desamparados Escudero-García; Laura Purchades; Manuel Rodríguez; Juan E. Losa-García; María L. Gutiérrez; Isabel Carmona; Javier García-Samaniego; Luís Morano; Ignacio Martín-Granizo; Marta Montero-Alonso; Martín Prieto; Manuel Delgado; Natalia Ramos; María A. Azancot; Francisco Rodríguez-Frías; Maria Buti;